'Extreme duplication' in the USFDA adverse events reporting system database

被引：55
|
作者：
Reich, Lester
机构：
[1] Pfrizer Inc, Risk Management Strategy, Safety & Risk Management, New York, NY 10017 USA
[2] NYU, Dept Med, Sch Med, New York, NY USA
[3] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA
[4] New York Med Coll, Dept Community & Prevent Med, Valhalla, NY 10595 USA
[5] Brunel Univ, Sch Informat Comp & Math, London, England
来源：
DRUG SAFETY | 2007年 / 30卷 / 06期
关键词：
D O I：
10.2165/00002018-200730060-00009
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：551 / 554
页数：4
相关论文
共 50 条
  • [41] Evaluation of cardiac adverse events with ponatinib using a spontaneous reporting database
    Kanbayashi, Yuko
    Uchida, Mayako
    Nakano, Kana
    Wakabayashi, Haruka
    Shimizu, Tadashi
    [J]. ONCOLOGY, 2023, 101 (06) : 397 - 405
  • [42] A review of the Vaccine Adverse Event Reporting System database
    Geier, DA
    Geier, MR
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (03) : 691 - 698
  • [43] More extreme duplication in FDA Adverse Event Reporting System detected by literature reference normalization and fuzzy string matching
    Hung, Eric
    Hauben, Manfred
    Essex, Henry
    Zou, Chen
    Bright, Steve
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (03) : 387 - 391
  • [44] Adverse events reporting
    Higuchi, K.
    [J]. CLINICAL DRUG INVESTIGATION, 2007, 27 (03) : 225 - 225
  • [45] Adverse Events Reporting
    K. Higuchi
    [J]. Clinical Drug Investigation, 2007, 27 : 225 - 225
  • [46] Reporting of adverse events
    Woolf, A
    Litovitz, T
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14): : 1410 - 1411
  • [47] Vedolizumab Adverse Events: Analysis of the FDA Adverse Event Reporting System
    Jow, Steven
    Hutfless, Susan
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 : S35 - S36
  • [48] Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
    Sonawane, Kalyani B.
    Cheng, Ning
    Hansen, Richard A.
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 682 - 690
  • [49] COMMONLY REPORTED ADVERSE EVENTS ASSOCIATED WITH ANTICOAGULANTS USING FDA ADVERSE EVENT REPORTING SYSTEM DATABASE 2012-2018
    Costa, L.
    Hincapie, A.
    Guo, J. J.
    [J]. VALUE IN HEALTH, 2019, 22 : S163 - S163
  • [50] Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Subeesh, Viswam
    Maheswari, Eswaran
    Singh, Hemendra
    Beulah, Thomas Elsa
    Swaroop, Ann Mary
    [J]. CURRENT DRUG SAFETY, 2019, 14 (01) : 21 - 26
12345